📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT. (2010)

First Author: Chalandon Y

Attributed to: Expansion of the GMP facility for Stem Cell Therapy at Imperial College funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/bmt.2009.177

PubMed Identifier: 19633691

Publication URI: http://europepmc.org/abstract/MED/19633691

Type: Journal Article/Review

Volume: 45

Parent Publication: Bone marrow transplantation

Issue: 3

ISSN: 0268-3369